Becker K J, Baxter A B, Bybee H M, Tirschwell D L, Abouelsaad T, Cohen W A
Department of Neurology University of Washington School of Medicine, Harborview Medical Center, Seattle, Washington, USA.
Stroke. 1999 Oct;30(10):2025-32. doi: 10.1161/01.str.30.10.2025.
Hematomas that enlarge following presentation with primary intracerebral hemorrhage (ICH) are associated with increased mortality, but the mechanisms of hematoma enlargement are poorly understood. We interpreted the presence of contrast extravasation into the hematoma after CT angiography (CTA) as evidence of ongoing hemorrhage and sought to identify the clinical significance of contrast extravasation as well as factors associated with the risk of extravasation.
We reviewed the clinical records and radiographic studies of all patients with intracranial hemorrhage undergoing CTA from 1994 to 1997. Only patients with primary ICH were included in this study. Univariate and multivariate logistic regression analyses were performed to determine the associations between clinical and radiological variables and the risk of hospital death or contrast extravasation.
Data were available for 113 patients. Contrast extravasation was seen in 46% of patients at the time of CTA, and the presence of contrast extravasation was associated with increased fatality: 63.5% versus 16.4% in patients without extravasation (P=0.011). There was a trend toward a shorter time (median+/-SD) from symptom onset to CTA in patients with extravasation (4.6+/-19 hours) than in patients with no evidence of extravasation (6.6+/-28 hours; P=0.065). Multivariate analysis revealed that hematoma size (P=0.022), Glasgow Coma Scale (GCS) score (P=0.016), extravasation of contrast (P=0.006), infratentorial ICH (P=0.014), and lack of surgery (P<0.001) were independently associated with hospital death. Variables independently associated with contrast extravasation were hematoma size (P=0.024), MABP >120 mm Hg (P=0.012), and GCS score of </=8 (P<0.005).
Contrast extravasation into the hematoma after ICH is associated with increased fatality. The risk of contrast extravasation is increased with extreme hypertension, depressed consciousness, and large hemorrhages. If contrast extravasation represents ongoing hemorrhage, the findings in this study may have implications for therapy of ICH, particularly with regard to blood pressure management.
原发性脑出血(ICH)发病后血肿扩大与死亡率增加相关,但血肿扩大的机制尚不清楚。我们将CT血管造影(CTA)后血肿内造影剂外渗视为持续出血的证据,并试图确定造影剂外渗的临床意义以及与外渗风险相关的因素。
我们回顾了1994年至1997年所有接受CTA检查的颅内出血患者的临床记录和影像学研究。本研究仅纳入原发性ICH患者。进行单因素和多因素逻辑回归分析,以确定临床和放射学变量与医院死亡风险或造影剂外渗之间的关联。
113例患者的数据可用。CTA检查时,46%的患者出现造影剂外渗,造影剂外渗与死亡率增加相关:外渗患者的死亡率为63.5%,无外渗患者为16.4%(P=0.011)。外渗患者从症状发作到CTA的时间(中位数±标准差)(4.6±19小时)比无外渗证据的患者(6.6±28小时;P=0.065)有缩短趋势。多因素分析显示,血肿大小(P=0.022)、格拉斯哥昏迷量表(GCS)评分(P=0.016)、造影剂外渗(P=0.006)、幕下ICH(P=0.014)和未进行手术(P<0.001)与医院死亡独立相关。与造影剂外渗独立相关的变量是血肿大小(P=0.024)、平均动脉压(MABP)>120 mmHg(P=0.012)和GCS评分≤8(P<0.005)。
ICH后血肿内造影剂外渗与死亡率增加相关。极端高血压、意识障碍和大出血会增加造影剂外渗的风险。如果造影剂外渗代表持续出血,本研究结果可能对ICH的治疗有影响,特别是在血压管理方面。